Accelerate your royalty deal evaluation

Process complex healthcare IP documents and patent lifecycles 25x faster than your current workflow.

Trusted by private markets investors like Royalty Pharma, OMERS Life Sciences, and Drug Royalty Corporation.

SOC-2 Type-2 Audit Completed
Single Sign-on Supported
Best-in-class Encryption
GDPR- & CCPA-ready
Featured in renowned publications and trusted by industry leaders.
Challenges and Solutions

We Know What Keeps You Up at Night

Your data room complexity is slowing royalty diligence
Your team reviews hundreds of documents per deal—patent filings, clinical trial data, licensing agreements, and revenue projections across multiple therapeutic areas. With 50-200 CIMs hitting your desk annually, critical insights get buried and deal timelines slip.
How Brightwave Helps:

Brightwave Private Markets ingests your entire data room in under 30 seconds, automatically extracting patent expiry dates, royalty waterfall structures, and drug performance metrics. Your analysts spend time on analysis, not document hunting.

Your multi-strategy approach demands unified analysis
Your cross-asset collaboration strategy means evaluating royalty streams, credit instruments, and equity positions simultaneously. Synthesizing insights across these deal types into coherent IC memos creates bottlenecks and inconsistent outputs.
How Brightwave Helps:

Brightwave Private Markets processes diverse document sets—CIMs, financial models, legal agreements, market research—into unified investment analysis. Generate customizable reports using reusable templates that maintain consistency across your different strategies.

Your analysts are buried in last-minute memo revisions
When deal terms shift or new clinical data emerges, your team scrambles to restructure memos hours before IC meetings. These quality and timing pressures lead to analyst burnout and force you to choose between speed and thoroughness.
How Brightwave Helps:

Brightwave Private Markets generates IC-ready memos with full citations in hours, not days. When last-minute changes hit, instantly regenerate sections while maintaining document integrity—giving your team time back for strategic evaluation.

Your competitive edge depends on faster pipeline screening
While larger royalty funds deploy more capital, your operational value creation approach requires deeper diligence on each opportunity. But manually screening emerging therapeutic areas like gene therapy and rare diseases strains your resources against well-capitalized competitors.
How Brightwave Helps:

Brightwave Private Markets lets you screen more deals without expanding headcount. Rapidly analyze patent lifecycles, regulatory risks, and pricing exposure across your pipeline—helping you move decisively on opportunities before Royalty Pharma and others.

Case Studies

Example Category

Bridging the Gap: How Financial Firms Can Overcome Hurdles to AI Integration 2

Lorem ipsum dolor sit amet consectetur. Tortor volutpat volutpat id iaculis lectus arcu id. Hac at laoreet aliquet.

Example Category 2

Bridging the Gap: How Financial Firms Can Overcome Hurdles to AI Integration 3

Lorem ipsum dolor sit amet consectetur. Tortor volutpat volutpat id iaculis lectus arcu id. Hac at laoreet aliquet.

Example Category

Bridging the Gap: How Financial Firms Can Overcome Hurdles to AI Integration 4

Lorem ipsum dolor sit amet consectetur. Tortor volutpat volutpat id iaculis lectus arcu id. Hac at laoreet aliquet.

Brightwave Deal Impact

Click on any activity to see detailed time savings and how Brightwave accelerates your deal process.
Critical Impact (Significant Time Savings)
High Impact (Moderate Time Savings)
01
Phase duration:
Weeks 1-4
Sourcing & Initial Review
CRITICAL IMPACT
CIM Analysis
Associates, Analysts
HIGH IMPACT
Market Research
Associates, Senior Associates
HIGH IMPACT
Management Presentation Prep
Associates, VPs
02
Phase duration:
Weeks 7-14
Due Diligence
CRITICAL IMPACT
Data Room Review
Associates, Analysts
CRITICAL IMPACT
Customer/Vendor Contract Analysis
Associates, Legal Team
HIGH IMPACT
Reference Call Summaries
Associates, Senior Associates
HIGH IMPACT
DD Report Synthesis
VPs, Senior Associates
03
Phase duration:
Weeks 10-16
Financing & Documentation
HIGH IMPACT
Lender Presentation Materials
Associates, VPs
CRITICAL IMPACT
IC Memo Drafting
VPs, Principal
CRITICAL IMPACT
Legal Document Review
VPs, Legal Team
04
Phase duration:
Days 1-100
Post-Closing
HIGH IMPACT
Post-Closing Integration Planning
Operating Partners, VP
05
Phase duration:
Years 1-5
Ongoing Ownership
HIGH IMPACT
Board Materials Review
Partners, Portfolio Item

Brightwave ROI Calculator

See how much time and money your firm could save

What type of firm are you?

How many investment professionals on your team?

Include partners, principals, VPs, associates, and analysts

What's your annual deal activity?

What are your average labor costs?

$

Associates and analysts - typical range $150-250/hr

$

VPs and principals - typical range $300-500/hr

Ready to beat Royalty Pharma, OMERS Life Sciences, and Drug Royalty Corporation?

Let's build your competitive advantage.

Content You May Find Helpful

Brightwave Agents Get a Major Upgrade with Sonnet 4.5

We couldn't be more proud to be partnered with Anthropic to bring our professional-grade research tools to market.

Introducing Research Agents: Advancing Agentic Research for Professionals

Discover Brightwave's new research agents: autonomous AI research workers designed for finance and strategy professionals.

From One‑Shot Outputs to Living Intelligence: Why Structured AI Reports Win at Deep Research

Brightwave is the AI research platform that helps busy professionals understand the world's most complex problems.